stocks logo

UTMD Valuation

Utah Medical Products Inc
$
52.660
+0.460(+0.880%)
  • Overview
  • Forecast
  • Valuation

UTMD Relative Valuation

UTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UTMD is overvalued; if below, it's undervalued.

Historical Valuation

P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.48
P/B
Median3y
2.40
Median5y
2.71
0.00
FCF Yield
Median3y
6.45
Median5y
6.33

Competitors Valuation Multiple

The average P/S ratio for UTMD's competitors is 56.18, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -25.74%, this premium appears unsustainable.

FAQ

arrow icon

Is Utah Medical Products Inc (UTMD) currently overvalued or undervalued?

Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation methord.
arrow icon

What is Utah Medical Products Inc (UTMD) fair value?

arrow icon

How does UTMD's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Utah Medical Products Inc (UTMD) as of May 04 2025?

arrow icon

What is the current FCF Yield for Utah Medical Products Inc (UTMD) as of May 04 2025?

arrow icon

What is the current Forward P/E ratio for Utah Medical Products Inc (UTMD) as of May 04 2025?

arrow icon

What is the current Forward P/S ratio for Utah Medical Products Inc (UTMD) as of May 04 2025?